Midland Energy Resources‚ Cost of Capital The case is about how Janet Mortensen‚ senior vice president of project finance for Midland Energy Resources‚ prepare her annual cost of capital estimates for midland and each of its three divisions for her company. Midland was a global energy company with operations in oil and gas exploration and production (E&P)‚ refining and marketing(R&M)‚ and petrochemicals. Estimates of cost of capital prepared by Mortensen were used in many analyses within
Premium Mathematics Weighted average cost of capital Investment
Nike‚ Inc.: Cost of Capital Case 14 A Case Brief Submitted to Submitted by In Partial Fulfillment of the Requirements for Date Submitted September 28‚ 2011 Summary This case highlights Kimi Ford‚ a portfolio manager with NorthPoint Group‚ a mutual-fund management firm. She managed the NorthPoint Large-Cap Fund‚ and in July of 2001‚ was looking at the possibility of taking a position in Nike for her fund. Nike stock had declined significantly over the previous year‚ and it appeared
Premium Interest Arithmetic mean Finance
A substantial number of empirical studies have investigated the overreaction hypothesis to ascertain whether overreaction has led to subsequent price reversals in the short-term period. While those studies focus on the world’s largest markets i.e. U.S. and Japan‚ other emerging and developing markets are largely unexplored. This motivates us to further investigate the issue in Vietnamese stock market. Applying Generalized Method of Moments approach on a sample size of 33 firms listed on
Premium Stock market Financial markets
Merck and Co.‚ River Blindness Ethical Case Analysis Lennard de Jong Excelsior College Author Note This paper was prepared for Business Ethics‚ Ethical Case Analysis‚ taught by Dr. Moser. Introduction and Situational Analysis The ethical dilemma in Merck and River Blindness is whether to pursue research that may or may result in profit‚ or to choose the safe option and go for profit rather than researching the drug. The drug could possibly lead to curing the deadly and detrimental disease
Premium Ethics Morality
in a business. The most promising opportunity at the time was in building supplies‚ so Low bought a business that specialized in sales of one size of nail. The annual volume of nails was 2‚000 kegs‚ and they were sold to retail customers in an even flow. Low was uncertain of how many nails to order at any time. Initially‚ only two costs concerned him: order-processing costs‚ which were $60 per order without regard to size‚ and warehousing costs‚ which were $1 per year per keg space. On average‚ the
Premium Time Question
HBR.ORG Do You Know Your Cost of Capital? Probably not‚ if your company is like most by Michael T. Jacobs and Anil Shivdasani July–AuGust 2012 reprinT r1207L For arTicLe reprinTs caLL 800-988-0886 or 617-783-7500‚ or visiT hbr.org Do You Know Your Cost Of Capital? probably not‚ if your company is like most by Michael T. Jacobs and Anil Shivdasani W With trillions of dollars in cash sitting on their balance sheets‚ corporations have never had so much money. How executives
Premium Investment Net present value Finance
Merck is a pharmaceutical company that we often see on television for their prescription drug ads. They were known for their ability to produce 13 new drugs from 1995 to 2001‚ of which included the painkiller Vioxx. The drug was supposed to beat out Pfizer’s‚ Celebrex‚ and Bextra because it was gentler on the stomach. (www.cbsnews.com) But was that the only thing different Vioxx could do? Vioxx was introduced in 1999. Almost immediately reports started pouring in about patients having complications
Premium Pharmacology Pharmaceutical drug Drug
In the year 2000‚ Merck produced a controversial product called Vioxx. Four years later it gained worldwide attention because of the drug’s potential cardiovascular risks. This was detrimental to the company’s reputation because it was alleged Merck knowingly distributed Vioxx despite its risk. Both Barbara Martinez and Anne W. Mathews of the Wall Street Journal wrote articles into the investigation of Vioxx. Their article suggests Merck knew the dangers of Vioxx at an early stage of its clinical
Premium Clinical trial
WACC Weighted Average Cost of Capital Formula The WACC Weighted Average Cost of Capital formula is complex‚ and can be broken into several components. The individual component costs are provided in the following sections. WACC Weighted Average Cost of Capital Variables V=Firm Total Value (Debt + Preferred Shares + Common Equity + Retained Earnings) Md=Market Value of Debt Mp=Market Value of Preferred Shares Mc=Market Value of Common Equity Mr=Market Value of Retained Earnings K=Current
Premium Finance Weighted average cost of capital
liabilities patterns feasible under the alternative production plans. What implications do their differences have for the risk assumed by the various parties? Hampton Machine Tool 1. Why can’t a profitable firm like Hampton repay its loan on time and why does it need more bank financing? What major developments between November 1978 and August 1979 contributed to this situation? 2. Based on the information in the case‚ prepare a projected cash budget for the four months September through
Premium Weighted average cost of capital Cash flow Net present value